- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
**Financial Highlights:**
Vijaya Diagnostic Centre posted INR 1,690 Mn in revenue from operations for Q3 FY25, reflecting a year-on-year growth of 27.3%. Excluding the impact from the recently acquired PH Diagnostic Centre, revenue growth was 20.0%. EBITDA was reported at INR 671 Mn with a margin of 39.7%, while PAT stood at INR 352 Mn, resulting in a PAT margin of 20.8%. For the nine months ending December 31, 2024, revenue reached INR 5,081 Mn, yielding a PAT of INR 1,084 Mn.
**Strategic Initiatives and Growth Drivers:**
The company has solidified its expansion plans with the operationalization of a new hub in Pune and future hubs anticipated in Bengaluru and West Bengal. Six new hubs are expected to launch in the upcoming three months, reinforcing its commitment to growth.
**Business Developments:**
Vijaya successfully integrated PH Diagnostic Centre, expanding its footprint in Pune. Additionally, a new state-of-the-art hub in Nizamabad has launched to bolster services in Tier II and III markets.
**Market Position and Competitive Advantage:**
With a strong B2C revenue composition (93%), Vijaya leverages its integrated business model to drive profitability. The expansion into new regions supports significant growth potential.
**Investor Implications:**
Given the robust growth trajectory and strategic expansions, Vijaya’s outlook appears positive. Investors should monitor ongoing developments as the company enhances its market presence and operational capabilities.